合計 50 件の最近のインサイダー取引記録が記録されています Kezar Life Sciences, Inc. (KZR), 内訳は 31 件の買い および 16 件の売り. インサイダー買い総額は $3.5M インサイダー売り総額は $10.62M.
最近活動のある主要インサイダーには Schiller Mark C., Chiang Pichi Luo, To Zung Phuong. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — KZR
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-07-02 |
Schiller Mark C. |
Chief Operating Officer |
情報に基づく売り |
561 |
$4.28 |
$2.4K |
2,739 |
| 2025-07-02 |
Chiang Pichi Luo |
SVP, Corporate Controller |
情報に基づく売り |
264 |
$4.28 |
$1.13K |
2,711 |
| 2025-07-01 |
To Zung Phuong |
Chief Development Officer |
RSU 付与（制限付株式） |
7,000 |
$4.40 |
$30.8K |
7,000 |
| 2025-06-18 |
Berger Franklin M |
Director |
RSU 付与（制限付株式） |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Kauffman Michael |
Director |
RSU 付与（制限付株式） |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Cooper Graham K |
Director |
RSU 付与（制限付株式） |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Garner Elizabeth |
Director |
RSU 付与（制限付株式） |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Fowler John Franklin |
Director |
RSU 付与（制限付株式） |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Wallace Courtney |
Director |
RSU 付与（制限付株式） |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Klearman Micki |
Director |
RSU 付与（制限付株式） |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-04-01 |
Chiang Pichi Luo |
SVP, Corporate Controller |
不明 |
17,500 |
$6.58 |
$115.15K |
- |
| 2025-04-01 |
To Zung Phoung |
SVP, Clinical Development |
不明 |
20,000 |
$6.58 |
$131.6K |
- |
| 2025-03-27 |
Belsky Marc |
Chief Financial Officer |
RSU 付与（制限付株式） |
4,800 |
$6.30 |
$30.24K |
12,000 |
| 2025-03-27 |
Schiller Mark C. |
Chief Legal Officer |
RSU 付与（制限付株式） |
4,800 |
$6.30 |
$30.24K |
12,000 |
| 2025-03-04 |
Belsky Marc |
Chief Financial Officer |
RSU 付与（制限付株式） |
7,200 |
$6.30 |
$45.36K |
7,200 |
| 2025-03-04 |
Schiller Mark C. |
Chief Legal Officer |
RSU 付与（制限付株式） |
7,200 |
$6.30 |
$45.36K |
7,200 |
| 2025-02-14 |
Fowler John Franklin |
Director |
RSU 付与（制限付株式） |
5,000 |
$5.89 |
$29.45K |
5,000 |
| 2025-01-09 |
Belsky Marc |
Chief Financial Officer |
RSU 付与（制限付株式） |
24,500 |
$6.58 |
$161.21K |
24,500 |
| 2025-01-09 |
Kirk Christopher J. |
CEO |
RSU 付与（制限付株式） |
120,000 |
$6.58 |
$789.6K |
120,000 |
| 2025-01-09 |
Schiller Mark C. |
Chief Legal Officer |
RSU 付与（制限付株式） |
24,500 |
$6.58 |
$161.21K |
24,500 |
| 2024-07-02 |
Schiller Mark C. |
Chief Legal Officer |
情報に基づく売り |
6,688 |
$0.58 |
$3.88K |
33,007 |
| 2024-06-20 |
Berger Franklin M |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Kauffman Michael |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Cooper Graham K |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Garner Elizabeth |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Wallace Courtney |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Klearman Micki |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-01-15 |
Schiller Mark C. |
Chief Legal Officer |
処分 |
250,000 |
$0.93 |
$232.5K |
- |
| 2024-01-07 |
Belsky Marc |
Chief Financial Officer |
RSU 付与（制限付株式） |
295,000 |
$0.93 |
$274.35K |
295,000 |
| 2024-01-07 |
Mordwinkin Nicholas Michael |
Chief Business Officer |
RSU 付与（制限付株式） |
275,000 |
$0.93 |
$255.75K |
275,000 |
| 2023-11-08 |
Kirk Christopher J. |
CEO |
RSU 付与（制限付株式） |
875,000 |
$0.84 |
$735K |
875,000 |
| 2023-08-15 |
Morningside Venture Investments Ltd |
10 Percent Owner |
贈与（送付） |
3,500,000 |
- |
- |
1,947,993 |
| 2023-07-24 |
Berger Franklin M |
Director |
株式返還 |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Kauffman Michael |
Director |
株式返還 |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Belsky Marc |
Chief Financial Officer |
株式返還 |
195,000 |
$6.84 |
$1.33M |
- |
| 2023-07-24 |
Cooper Graham K |
Director |
株式返還 |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Garner Elizabeth |
Director |
株式返還 |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Kirk Christopher J. |
Director |
株式返還 |
190,000 |
$6.84 |
$1.3M |
- |
| 2023-07-24 |
Fowler John Franklin |
CEO |
株式返還 |
175,000 |
$22.85 |
$4M |
- |
| 2023-07-24 |
Wallace Courtney |
Director |
株式返還 |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Henig Noreen |
Chief Medical Officer |
株式返還 |
220,000 |
$6.84 |
$1.5M |
- |
| 2023-07-24 |
Klearman Micki |
Director |
株式返還 |
52,000 |
$5.94 |
$308.88K |
- |
| 2023-07-24 |
Mordwinkin Nicholas Michael |
Chief Business Officer |
株式返還 |
185,000 |
$6.84 |
$1.27M |
- |
| 2023-07-20 |
Kirk Christopher J. |
Director |
オプション行使（売却） |
48,950 |
$0.90 |
$44.06K |
74,411 |
| 2023-06-15 |
Berger Franklin M |
Director |
RSU 付与（制限付株式） |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Kauffman Michael |
Director |
RSU 付与（制限付株式） |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Cooper Graham K |
Director |
RSU 付与（制限付株式） |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Garner Elizabeth |
Director |
RSU 付与（制限付株式） |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Wallace Courtney |
Director |
RSU 付与（制限付株式） |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Klearman Micki |
Director |
RSU 付与（制限付株式） |
35,000 |
$2.64 |
$92.4K |
35,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
